VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into InMed Pharmaceuticals Inc. (INM) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - Specialty & Generic · market value about $9.0M · revenue $4.5M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows